Insider Trading Activity For Bioverativ Inc (NASDAQ:BIVV)
Brian S Posner , Director of Bioverativ Inc (NASDAQ:BIVV) reportedly Bought 1,000 shares of the company’s stock at an average price of 59.19 for a total transaction amount of $59,190.00 SEC Form
Insider Trading History For Bioverativ Inc (NASDAQ:BIVV)
Analyst Ratings For Bioverativ Inc (NASDAQ:BIVV)
These are 1 Sell Rating, 7 Hold Ratings, 5 Buy Ratings, 1 Strong Buy Rating .
The current consensus rating for Bioverativ Inc (NASDAQ:BIVV) is Hold (Score: 2.43) with a consensus target price of $59.58 , a potential (5.44% upside)
Analyst Ratings History For Bioverativ Inc (NASDAQ:BIVV)
- On 2/7/2017 Raymond James Financial, Inc. Initiated Coverage of rating Strong-Buy with a price target of $59.00
- On 2/8/2017 Morgan Stanley Reiterated Rating Underweight with a price target of $41.00
- On 2/28/2017 Piper Jaffray Companies Upgraded rating Neutral to Overweight with a price target of $44.00 to $65.00
- On 3/13/2017 Goldman Sachs Group, Inc. (The) Downgraded rating Buy to Neutral with a price target of $55.00
- On 3/27/2017 Stifel Nicolaus Boost Price Target of rating Buy to Buy with a price target of $54.00 to $57.00
- On 3/28/2017 Leerink Swann Set Price Target of rating Buy with a price target of $62.00
- On 3/31/2017 Argus Initiated Coverage of rating Hold to Hold with a price target of $51.00
Recent Trading Activity for Bioverativ Inc (NASDAQ:BIVV)
Shares of Bioverativ Inc closed the previous trading session at 56.51 down -2.56 -4.33% with 1,196,696 shares trading hands.